Document is current
Any future updates will be listed below
-
Authors
Cesari, Eleonora
Ciucci, Alessandra
Pieraccioli, Marco
Caggiano, Cinzia
Nero, Camilla
Bonvissuto, Davide
Sillano, Francesca
Buttarelli, Marianna
Piermattei, Alessia
Loverro, Matteo
Camarda, Floriana
Greco, Viviana
De Bonis, Maria
Minucci, Angelo
Gallo, Daniela
Urbani, Andrea
Vizzielli, Giuseppe
Scambia, Giovanni
Sette, Claudio http://orcid.org/0000-0003-2864-8266
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG23416)
Ministero della Salute (GR 2019-12371435, Ricerca Corrente 2022)
- License Information
-
More Information
Article History
Received: 21 February 2023
Accepted: 21 April 2023
First Online: 18 May 2023
Declarations
:
: Clinical studies were approved by the local Ethics Committee and Institutional Review Board (Protocol ID: 3046 and Protocol ID 2045) and were conducted in accordance with the European Good Clinical Practice requirements (Declaration of Helsinki). All patients enrolled gave their written informed consent for participation.
: Not applicable.
: The authors E.C., A.C, M.P., C.C, D.B., F.S., M.B., A.P., M.L., F.C., D.G., V.G., M.D.B., A.M., A.U., G.V., G.S. and C.S. declare no potential conflicts of interest.C.N. declares Travel support by MSD (Merck & Co., Inc.) and Illumina.
